Clinuvel Pharmaceuticals Ltd (CLVLF)
Market Closed
12 Jun, 20:00
$
6. 10
0
0%
$
343.8M Market Cap
- P/E Ratio
- Div Yield
1,500 Volume
- Eps
$ 6.1
Previous Close Want to track CLVLF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clinuvel Pharmaceuticals Ltd (CLVLF) Statistics
Valuation metrics
Market Cap 343.8M
Enterprise value 415.88M
Trailing P/E (ttm) 13.81
Forward P/E -
PEG ratio -0.89
Price/Sales (ttm) 4.69
Price/Book (mrq) 1.8
Enterprise Value/Revenue 4.32
Enterprise Value/EBITDA 9.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 187
Average volume (90 days) 287
Price summary
52-Week low 6.1
52-Week high 8.6
Beta -
50-Day moving average 6.51
200-Day moving average 7.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.05
Trailing annual dividend yield 0.0056%
5-Year annual dividend yield -
Payout ratio 0.08
Dividend Date 19 Sep 2025
Ex-Dividend Date 5 Sep 2025
Last split factor 1:10
Last split Date 18 Nov 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.34%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.92
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 14.64%
Book value per share (mrq) 4.96
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
